Skip to content
Home/Companies/Santé / Bien-être/ACTIVE BIOMARKERS

ACTIVE BIOMARKERS

Santé / Bien-être·France·Exited 2022·Held 2yr
Entry
2020
Hold
2yr
Exit
2022

Who owns ACTIVE BIOMARKERS?

ACTIVE BIOMARKERS was owned by Turenne Groupe through Capital Santé 2 (2020 vintage) from 2020 to 2022, exited via Trade Sale.

Buyer identity available on Pro.

Hand-verified · updated 2026-04-21

Turenne Groupe
Investor
Turenne Groupe
Capital Santé 2 · 2020 · Growth

Key facts

HQFrance
SectorSanté / Bien-être
Exit Type
Trade Sale
Buyer
MOIC
–
Exit Year
2022

More from Capital Santé 2

Other portfolio companies in the same fund.

Le Petit Souk
Active
E-commerceFrance· 2026
M&C3i
Active
SoftwareFrance· 2026
Agrotech
Active
ConstructionFrance· 2025
Anothercorp.
Active
ConsumerFrance· 2025
Groupe Colibri – Promesse de Fleurs
Active
ConsumerFrance· 2025
Kimialys
Active
IndustrialsFrance· 2025

More PE-backed in Healthcare

Comparable healthcare deals from other GPs.

3i – Implant Innovations Inc.
Active
Advent InternationalUS
Abacus Pharmaceuticals
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
Abode Healthcare
Active
Summit PartnersUS
AccentCare
AccentCare
Active
Advent InternationalUS
Acentra Health
Acentra Health
Active
The Carlyle GroupUS
AdipoPharma
AdipoPharma
Active
Capital Grand EstFrance
Track Active Biomarkers

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Active Biomarkers?

0 strategic and 120financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Active Biomarkers.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue